Arrowhead Pharmaceuticals, Inc. (FRA:HDP1)
Germany
· Delayed Price · Currency is EUR 52.64
-2.74 (-4.95%)
At close: Dec 5, 2025
Arrowhead Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2016 |
| Net Income | -1.63 | -599.49 | -205.28 | -176.06 | -140.85 | Upgrade
|
| Depreciation & Amortization | 23.93 | 18.6 | 12.49 | 10.42 | 8.27 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 0.08 | - | 4.43 | -1.71 | Upgrade
|
| Stock-Based Compensation | 63.37 | 73.97 | 78.13 | 120.89 | 76.67 | Upgrade
|
| Other Operating Activities | 112.12 | 18.91 | 12.31 | 2.48 | 0.27 | Upgrade
|
| Change in Accounts Receivable | -56.97 | - | 1.41 | 8.85 | -9.41 | Upgrade
|
| Change in Accounts Payable | 6.29 | -5.54 | 33 | -6.59 | 2.63 | Upgrade
|
| Change in Unearned Revenue | 2.4 | -0.87 | -129.18 | -112.5 | 223.26 | Upgrade
|
| Change in Other Net Operating Assets | 30.05 | 31.49 | 43.23 | 11.95 | 12.19 | Upgrade
|
| Operating Cash Flow | 179.55 | -462.85 | -153.89 | -136.13 | 171.31 | Upgrade
|
| Capital Expenditures | -22.67 | -141.47 | -176.74 | -52.78 | -23.57 | Upgrade
|
| Investment in Securities | -106.63 | -278.6 | 80.58 | 47.36 | -118.11 | Upgrade
|
| Investing Cash Flow | -129.29 | -420.07 | -96.16 | -5.42 | -141.68 | Upgrade
|
| Short-Term Debt Issued | 10.26 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 392 | - | - | - | Upgrade
|
| Total Debt Issued | 10.26 | 392 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -201.63 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -191.37 | 392 | - | - | - | Upgrade
|
| Issuance of Common Stock | 245.37 | 431.65 | 3.05 | 5.19 | 11.31 | Upgrade
|
| Other Financing Activities | 20 | 46.87 | 250 | 60 | - | Upgrade
|
| Financing Cash Flow | 74.01 | 870.52 | 253.05 | 65.19 | 11.31 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.4 | 4.2 | -0.12 | -0.07 | -0.09 | Upgrade
|
| Net Cash Flow | 123.86 | -8.21 | 2.89 | -76.43 | 40.85 | Upgrade
|
| Free Cash Flow | 156.89 | -604.32 | -330.63 | -188.91 | 147.75 | Upgrade
|
| Free Cash Flow Margin | 18.92% | -17018.31% | -137.34% | -77.67% | 106.84% | Upgrade
|
| Free Cash Flow Per Share | 1.17 | -5.04 | -3.10 | -1.79 | 1.42 | Upgrade
|
| Cash Interest Paid | 0.02 | - | - | - | - | Upgrade
|
| Cash Income Tax Paid | -0.81 | 3.74 | - | 0 | 0 | Upgrade
|
| Levered Free Cash Flow | 106.45 | -440.13 | -251.42 | -60.64 | 63 | Upgrade
|
| Unlevered Free Cash Flow | 162.3 | -419.91 | -239.96 | -60.64 | 63 | Upgrade
|
| Change in Working Capital | -18.24 | 25.09 | -51.55 | -98.29 | 228.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.